Kalika Miller Pitcher, PA-C | |
912 Somerset Blvd Ste 102, Charles Town, WV 25414-3952 | |
(304) 725-2273 | |
(304) 725-0053 |
Full Name | Kalika Miller Pitcher |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 10 Years |
Location | 912 Somerset Blvd Ste 102, Charles Town, West Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720485956 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 01869 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jefferson Medical Center | Ranson, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug-one with no known medical potential-to a schedule IV drug such as prescription sleep aids, but with tighter control.
Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world's premier annual meeting for interventional cardiologists.
Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.
Euthymics Bioscience, Inc., a privately held Delaware corporation, today announced that it has signed a non-binding Letter of Intent (LOI) to merge into and acquire DOV Pharmaceutical, Inc. (DOV), a Delaware corporation currently traded on the Pink Sheets, for $2.0 million in cash plus payment of certain of DOV's expenses. DOV believes that the contemplated $2.0 million cash payment to shareholders represents approximately $0.015 per share of DOV common stock. If the transaction is consummated, it is anticipated that DOV will be renamed Euthymics Bioscience, Inc.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kalika Miller Pitcher, PA-C 2500 Foundation Way, Martinsburg, WV 25401-9000 Ph: (304) 264-9202 | Kalika Miller Pitcher, PA-C 912 Somerset Blvd Ste 102, Charles Town, WV 25414-3952 Ph: (304) 725-2273 |
News Archive
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug-one with no known medical potential-to a schedule IV drug such as prescription sleep aids, but with tighter control.
Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world's premier annual meeting for interventional cardiologists.
Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.
Euthymics Bioscience, Inc., a privately held Delaware corporation, today announced that it has signed a non-binding Letter of Intent (LOI) to merge into and acquire DOV Pharmaceutical, Inc. (DOV), a Delaware corporation currently traded on the Pink Sheets, for $2.0 million in cash plus payment of certain of DOV's expenses. DOV believes that the contemplated $2.0 million cash payment to shareholders represents approximately $0.015 per share of DOV common stock. If the transaction is consummated, it is anticipated that DOV will be renamed Euthymics Bioscience, Inc.
› Verified 3 days ago
Abigail Hubble Salser, Physician Assistant Medicare: Medicare Enrolled Practice Location: 84 Somerset Blvd, Charles Town, WV 25414 Phone: 703-909-7894 | |
Mrs. Brittany Marie Herber, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 912 Somerset Blvd Ste 101, Charles Town, WV 25414 Phone: 304-725-2663 Fax: 304-724-0053 | |
Anthony W. Casto, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 912 Somerset Blvd, Suite 101, Charles Town, WV 25414 Phone: 304-725-2663 Fax: 304-724-0053 | |
Mr. Jason Lincoln, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 84 Somerset Blvd, Charles Town, WV 25414 Phone: 304-728-8533 |